207 related articles for article (PubMed ID: 23916489)
1. Purification of eukaryotic tetherin/Vpu proteins and detection of their interaction by ELISA.
Lv M; Zhu Y; Wang J; Zhang H; Wang X; Zuo T; Liu D; Zhang J; Wu J; Kong W; Yu X
Protein Expr Purif; 2013 Oct; 91(2):112-8. PubMed ID: 23916489
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of inactive tetherin delGPI mutant inhibits HIV-1 Vpu-mediated antagonism of endogenous tetherin.
Lv M; Wang J; Zhu Y; Wang X; Zuo T; Liu D; Zhang J; Wu J; Zhang H; Kong W; Yu X
FEBS Lett; 2013 Jan; 587(1):37-43. PubMed ID: 23201263
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin.
Fritz JV; Tibroni N; Keppler OT; Fackler OT
Virology; 2012 Mar; 424(1):33-44. PubMed ID: 22222210
[TBL] [Abstract][Full Text] [Related]
4. Vpu binds directly to tetherin and displaces it from nascent virions.
McNatt MW; Zang T; Bieniasz PD
PLoS Pathog; 2013; 9(4):e1003299. PubMed ID: 23633949
[TBL] [Abstract][Full Text] [Related]
5. Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity.
Lv M; Wang J; Wang X; Zuo T; Zhu Y; Kong W; Yu X
PLoS One; 2011; 6(6):e20890. PubMed ID: 21674066
[TBL] [Abstract][Full Text] [Related]
6. Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions.
Yoshida T; Koyanagi Y; Strebel K
J Virol; 2013 Dec; 87(24):13825-36. PubMed ID: 24109238
[TBL] [Abstract][Full Text] [Related]
7. βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin.
Song YE; Cyburt D; Lucas TM; Gregory DA; Lyddon TD; Johnson MC
Viruses; 2018 Oct; 10(10):. PubMed ID: 30347660
[TBL] [Abstract][Full Text] [Related]
8. Counteraction of tetherin antiviral activity by two closely related SIVs differing by the presence of a Vpu gene.
Nikovics K; Dazza MC; Ekwalanga M; Mammano F; Clavel F; Saragosti S
PLoS One; 2012; 7(4):e35411. PubMed ID: 22530020
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification and characterization of a full-length recombinant HIV-1 Vpu from inclusion bodies.
Njengele Z; Kleynhans R; Sayed Y; Mosebi S
Protein Expr Purif; 2016 Dec; 128():109-14. PubMed ID: 27590917
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
[TBL] [Abstract][Full Text] [Related]
11. Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.
Vigan R; Neil SJ
J Virol; 2010 Dec; 84(24):12958-70. PubMed ID: 20926557
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane interactions of HIV-1 Vpu and tetherin.
Guo F; Liang C
Curr HIV Res; 2012 Jun; 10(4):292-7. PubMed ID: 22524177
[TBL] [Abstract][Full Text] [Related]
13. Recombinant expression, purification, and characterization of full-length human BST-2 from Escherichia coli.
Marivate A; Njengele-Tetyana Z; Fish MQ; Mosebi S
Protein Expr Purif; 2021 Dec; 188():105969. PubMed ID: 34500069
[TBL] [Abstract][Full Text] [Related]
14. Vpu downmodulates two distinct targets, tetherin and gibbon ape leukemia virus envelope, through shared features in the Vpu cytoplasmic tail.
Lucas TM; Janaka SK; Stephens EB; Johnson MC
PLoS One; 2012; 7(12):e51741. PubMed ID: 23284757
[TBL] [Abstract][Full Text] [Related]
15. Lack of adaptation to human tetherin in HIV-1 group O and P.
Yang SJ; Lopez LA; Exline CM; Haworth KG; Cannon PM
Retrovirology; 2011 Sep; 8():78. PubMed ID: 21955466
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Vpu and BST-2/tetherin: enemies at the gates.
Tokunaga K
Curr HIV Res; 2012 Jun; 10(4):275-6. PubMed ID: 22533470
[No Abstract] [Full Text] [Related]
17. [Establishment of a high-throughput screening assay for interaction inhibitor between BST-2 and Vpu].
Pang XJ; Hu SQ; Zhang Y; Cen S; Jin Q; Guo F
Bing Du Xue Bao; 2012 Nov; 28(6):633-8. PubMed ID: 23367562
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of the host restriction factor tetherin in viral immune sensing.
Hotter D; Sauter D; Kirchhoff F
J Mol Biol; 2013 Dec; 425(24):4956-64. PubMed ID: 24075872
[TBL] [Abstract][Full Text] [Related]
19. Vpu of a Simian Immunodeficiency Virus Isolated from Greater Spot-Nosed Monkey Antagonizes Human BST-2 via Two AxxxxxxxW Motifs.
Yao W; Yoshida T; Hashimoto S; Takeuchi H; Strebel K; Yamaoka S
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666374
[TBL] [Abstract][Full Text] [Related]
20. Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317.
Bolduan S; Votteler J; Lodermeyer V; Greiner T; Koppensteiner H; Schindler M; Thiel G; Schubert U
Virology; 2011 Jul; 416(1-2):75-85. PubMed ID: 21601230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]